About 400 reports

THE ONCOLOGY SEGMENT IS FURTHER SUB-SEGMENTED INTO HEAD AND NECK CANCER, STOMACH & GASTROINTESTINAL CANCER, LIVER CANCER, PANCREATIC CANCER, ESOPHAGEAL CANCER, AND OTHER CANCERS.

  • Hospital
  • World
  • Forecast
  • Market Size
  • Cardinal Health, Inc.
  • HEAD AND NECK CANCER

IN 2019, ABOUT ##, ## NEW ESOPHAGEAL CANCER CASES WERE DIAGNOSED IN THE US.

  • Hospital
  • World
  • Forecast
  • Market Size
  • Varian Medical Systems, Inc.

Chapter ## provides an introduction to the report.

  • Health Services
  • Hospital
  • Pharmaceutical
  • United States
  • Demand

Global Vaccine Partnering Terms and Agreements 2014-2020: Deal trends, players and financials Executive Summary Chapter ## – Introduction Chapter ## – Trends in Oncology dealmaking ##. ##.

  • Hospital
  • Pharmaceutical
  • Therapy
  • United States
  • Social Conditions

Ono Pharmaceutical plans to file its anti-PD-## antibody Opdivo (nivolumab) in Japan for an additional indication of second-line esophageal cancer in January-March 2019, President Gyo Sagara revealed on November ##.

  • Hospital
  • North America
  • United States
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company

Global Academic and Non-Profit Partnering Terms and Agreements 2014-2020: Deal trends, players and financials Executive Summary Chapter ## – Introduction Chapter ## – Trends in Academic and Non-Profit dealmaking ##. ##.

  • Hospital
  • Therapy
  • United States
  • Demand
  • Social Conditions

Chapter ## provides an introduction to the report, whilst chapter ## provides an overview of why companies partner discovery stage compounds/ products.

  • Hospital
  • Pharmaceutical
  • Therapy
  • United States
  • Demand

Ono Pharmaceutical plans to file its anti-PD-## antibody Opdivo (nivolumab) in Japan for an additional indication of second-line esophageal cancer in January-March 2019, President Gyo Sagara revealed on November ##.

  • Hospital
  • United States
  • Amgen Inc.
  • Biofrontera AG
  • Biosceptre International Limited

Particularly, among all cancers, patients with stomach cancer, head and neck cancer, and esophageal cancer need tube feeding due to the higher prevalence of swallowing problems and dysphagia.

  • Clinical Nutrition
  • Hospital
  • Pharmaceutical
  • World
  • Market Size

Colorectal cancer is one of the most common cancers in the country.

  • Hospital
  • World
  • Forecast
  • CapsoVision, Inc.
  • Medtronic, Inc.
  • Increasing Patient Population with Malnutrition & Aging

Globally, about ## in ## deaths is due to cancer.

  • Hospital
  • Nutrition
  • World
  • Market Size
  • Fresenius Group

Also, around one in six deaths occur mainly due to cancer.

  • Hospital
  • World
  • Market Size
  • Baxter International Inc.
  • Fresenius Group

Technological advancements in endoscopy have led to the development of ultra-MI thoracic procedures, which can be performed on patients with the benign esophageal disease and early-stage esophageal cancer.

  • Hospital
  • Surgery
  • World
  • Forecast
  • Market Size

India witnesses a prevalence of more than ## million new cases of cancer annually.

  • Hospital
  • North America
  • United States
  • World
  • Forecast

These gastroscopes are used to identify objects stuck in the esophagus, esophageal cancer, and Barrett' s syndrome.

  • Hospital
  • World
  • Forecast
  • FUJIFILM Holdings Corporation
  • Olympus Corporation

The lifetime risk of developing colorectal cancer is ## in ##.

  • Hospital
  • North America
  • World
  • Market Size
  • Boston Scientific Corporation

In these areas, lung cancer, gastric cancer and esophageal cancer take up the larger proportion and happen more on male than female, because overall male lung-cancer risks associate with cigarette smoking and Esophageal cancer link to fa

  • Hospital
  • China
  • Demand
  • Supply
  • Novartis AG

DRIVING FACTORS OF GI ENDOSCOPY INCLUDE LIFESTYLE HABITS LIKE TOBACCO SMOKING AND ALCOHOL DRINKING, LOW VEGETABLE INTAKE AND LOW FRUIT INTAKE CAN BE CAUSATIVE TO ESOPHAGEAL CANCER MORTALITY IN CHINA.

  • Hospital
  • World
  • Market Size
  • FUJIFILM Holdings Corporation
  • Olympus Corporation

Similarly to AstraZeneca China, foreign company' s strategies, in relation to key operating/ high ROI therapeutic areas, is likely to be in innovative/ patented biologics in areas such as gastric cancer, oesophageal cancer, liver cancer (owing to high incidence

  • Hospital
  • China
  • East Asia
  • Fosun International Limited
  • Pfizer China

Also, obesity is on rise world over, which is fast emerging as number one risk factor for many cancer types which includes, breast (after menopause), colon and rectal, esophageal, endometrial, pancreatic, kidney, thyroid and gallbladder.

  • Hospital
  • World
  • Market Size
  • Bracco Imaging S.p.A.
  • GE Healthcare Limited

Also, the patient who has been operated for esophageal cancer requires the nutrition supplements through CVC.

  • Hospital
  • World
  • AngioDynamics, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated

Also, the patients who undergone surgery for esophageal cancer need nutrition supplements through CVC.

  • Hospital
  • World
  • B. Braun Medical
  • Edwards Lifesciences Corporation
  • Teleflex Incorporated

C=##& P=IROL-NEWSARTICLE& ID=## CANCER, NSCLC, ESOPHAGEAL CANCER AND GASTRIC CANCERS.

  • Hospital
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG

Further, the treatment for metastatic lung cancer is the commonly treated condition with airway stents which is one of the primary factors behind the market growth.

  • Hospital
  • World
  • Forecast
  • Boston Scientific Corporation
  • Teleflex Incorporated

Metastatic Breast Cancer Pertuzumab& Trastuzumab Phase ## Phase ## Phase ## Company / University Condition Product / Intervention Description Phase Peking University & Cell Biotech Co.

  • Hospital
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

Lung, liver, stomach, colorectal, breast and esophageal cancers are prevalent among the population worldwide.

  • Hospital
  • AngioDynamics, Inc.
  • B. Braun Medical
  • C.R. Bard, Inc.
  • Teleflex Incorporated
  • 6.1.3 BREAST CANCER

Varian will market the Bionix Esophageal APPLICATOR (E-APP) AND THE ANORECTAL APPLICATOR (AR-##) IN NORTH AMERICA.

  • Hospital
  • World
  • Market Size
  • Accuray Incorporated
  • Elekta Group

However, because the individual' s risk of developing esophageal cancer is low, even in those with reflux disease, the results should not justify reflux treatment solely as a cancer prevention measure.

  • Cancer
  • Hospital
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited
  • MEDIMMUNE ENTERS INTO RESEARCH AGREEMENT WITH CANCER RESEARCH INSTITUTE AND LUDWIG INSTITUTE FOR CANCER RESEARCH

The drug candidate acts by targeting indoleamine ##, ##-dioxygenase-## (IDO-##).

  • Hospital
  • Immunotherapy
  • United States
  • iTeos Therapeutics SA
  • Ludwig Institute For Cancer Research Ltd

It is one of the primary treatments used on patients with locally advanced prostate cancer.

  • Hospital
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Jude Medical, Inc.
  • Medtronic, Inc.